成分股GuardantHealth涨9.46%,TayshaGene涨8.37%,LyellImmunopharma涨8.07%

成分股GuardantHealth涨9.46%,TayshaGene涨8.37%,LyellImmunopharma涨8.07%,ArrowheadPharmaceuticals涨7.12%,SpringWorks涨6.96%,MarinusPharma涨6.88%,再鼎医药ADR涨6.54%,AvidityBio涨6.29%,CogentBiosciences涨6.11%,FulcrumTherapeutics和PrimeMedicine也涨5.99%;CentessaPharmaceuticals则收跌5.39%,LigandPharmaceuticals跌5.44%,DiscMedicine跌5.96%,VandaPharmaceuticals跌6.07%,NantKwest跌6.26%,bluebirdbio跌6.51%,AlxOncologyHoldings也跌8.78%。

相关推荐

封面图片

成分股MerusNV收涨36.12%,GuardantHealth涨13.37%,MorphicHolding涨10.95%,C

成分股MerusNV收涨36.12%,GuardantHealth涨13.37%,MorphicHolding涨10.95%,CogentBiosciences也涨9.75%;CureVacNV则收跌7.05%,Replimune跌7.77%,Ardelyx跌9.27%,AlxOncologyHoldings跌10.35%,SummitTherapeuticsPlc.跌21.76%。

封面图片

成分股OvidTherapeutics收跌76.00%,CabalettaBio、Humacyte、TourmalineBio、

成分股OvidTherapeutics收跌76.00%,CabalettaBio、Humacyte、TourmalineBio、PrimeMedicine跌12.20%-10.69%,BiomeaFusion也跌9.75%;万基遗传(MYGN)则收涨3.58%,CogentBiosciences涨4.45%,TangoTherapeutics涨5.04%,VeronaPharmaADR涨10.04%,MirumPharmaceuticals也涨27.31%。

封面图片

成分股LyellImmunopharma收跌36.03%,该公司针对三阴性乳腺癌疗法ROR1CAR-T候选药LYL979的早期临

成分股LyellImmunopharma收跌36.03%,该公司针对三阴性乳腺癌疗法ROR1CAR-T候选药LYL979的早期临床试验中,一名病患死亡;TayshaGene、BiomeaFusion、PrimeMedicine、AclarisTherapeutics、莫德纳(MRNA)、RocketPharma、AlxOncologyHoldings跌17.24%-10.50%,23AndmeHoldingCo.也跌9.05%;XerisPharmaceuticals、CoherusBioSciences、ARSPharmaceuticals、Arvinas、Erasca、SIGATech则收涨4.76%-6.11%。

封面图片

成分股医药研发公司DecipheraPharma收涨72.56%领跑,日本ONOPharmaceutical同意以每股25.60

成分股医药研发公司DecipheraPharma收涨72.56%领跑,日本ONOPharmaceutical同意以每股25.60美元现金收购DecipheraPharma,对股权的总体估值为24亿美元。PhibroAnimalHealth涨31.81%,NantKwest涨22.31%,JanuxTherapeutics涨18.34%,ExscientiaADR、PTCTherapeutics、CogentBiosciences、23AndmeHoldingCo.、DayOneBiopharmaceuticals、PrimeMedicine也涨14.64%-9.83%;VentyxBiosciences则收跌2.42%,RAPTTherapeutics、uniQureNV、ApellisPharma、Cytokinetics、CabalettaBio、AutolusTherapeutics跌2.72%-5.00%。

封面图片

成分股SummitTherapeuticsPlc.涨9.91%领跑,VoyagerTherapeutics涨9.34%,Anav

成分股SummitTherapeuticsPlc.涨9.91%领跑,VoyagerTherapeutics涨9.34%,AnavexLifeSciences涨8.02%,DayOneBiopharmaceuticals也涨5.13%;OmniAb目前则下跌2.07%,Replimune跌2.24%,ArcturusTherapeuticsHoldingsInc.跌3.75%,bluebirdbio跌18.39%目前表现最差。

封面图片

成分股中,Beam收涨16.47%领跑,PrimeMedicine、OricPharma、Arcutis、Humacyte、AT

成分股中,Beam收涨16.47%领跑,PrimeMedicine、OricPharma、Arcutis、Humacyte、ATAILifeSciencesBV、CastleBiosciences、Evolus、CullinanOncologyLLC、VeraTherapeutics、NantKwest、RecursionPharmaceuticals涨14.70%-10.02%,CaribouBiosciences也涨9.71%;杰龙(GERN)则收跌2.31%,SummitTherapeuticsPlc.、细胞动力科技CytokineticsIncorporated(CYTK)、ACImmune至多跌8.66%。

🔍 发送关键词来寻找群组、频道或视频。

启动SOSO机器人